Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer
Conclusion
While neoadjuvant ADT use decreased over the study period in men with unfavorable-risk PC undergoing brachytherapy, ADT use was not less likely in those with a history of CHF/MI.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cardiology | External Beam Therapy | Heart | Heart Attack | Heart Failure | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Prostate Cancer | Radiation Therapy | Study